| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.009 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |